The seventh edition of the UICC/AJCC staging system for nasopharyngeal carcinoma is prognostically useful for patients treated with intensity-modulated radiotherapy from an endemic area in China.
about
Emerging treatment options for nasopharyngeal carcinomaEvaluation of the efficacy and safety of a neoadjuvant gemcitabine and nedaplatin regimen followed by radiotherapy or concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma.Gemcitabine/cisplatin induction chemotherapy before concurrent chemotherapy and intensity-modulated radiotherapy improves outcomes for locoregionally advanced nasopharyngeal carcinoma.The Effect of Adding Neoadjuvant Chemotherapy to Concurrent Chemoradiotherapy in Patients with Locoregionally Advanced Nasopharyngeal Carcinoma and Undetectable Pretreatment Epstein-Barr Virus DNA.Combination of autoantibodies against NY-ESO-1 and viral capsid antigen immunoglobulin A for improved detection of nasopharyngeal carcinoma.Comparison of long-term survival and toxicity of cisplatin delivered weekly versus every three weeks concurrently with intensity-modulated radiotherapy in nasopharyngeal carcinomaPrimary tumor regression speed after radiotherapy and its prognostic significance in nasopharyngeal carcinoma: a retrospective study.Is maximum primary tumor diameter still a prognostic factor in patients with nasopharyngeal carcinoma treated using intensity-modulated radiotherapy?Leucopenia and treatment efficacy in advanced nasopharyngeal carcinoma.A retrospective study of the prognostic value of MRI-derived residual tumors at the end of intensity-modulated radiotherapy in 358 patients with locally-advanced nasopharyngeal carcinoma.Initial Hyperleukocytosis and Neutrophilia in Nasopharyngeal Carcinoma: Incidence and Prognostic ImpactPropensity-matched analysis of three different chemotherapy sequences in patients with locoregionally advanced nasopharyngeal carcinoma treated using intensity-modulated radiotherapy.Prognostic value of the primary lesion apparent diffusion coefficient (ADC) in nasopharyngeal carcinoma: a retrospective study of 541 cases.Establishment of an integrated model incorporating standardised uptake value and N-classification for predicting metastasis in nasopharyngeal carcinomaCXCL12 genetic variants as prognostic markers in nasopharyngeal carcinoma.Diffusion-weighted imaging to differentiate metastatic from non-metastatic retropharyngeal lymph nodes in nasopharyngeal carcinomaNeoadjuvant chemotherapy in locally advanced nasopharyngeal carcinoma: Defining high-risk patients who may benefit before concurrent chemotherapy combined with intensity-modulated radiotherapy.Chemoradiotherapy Versus Radiotherapy Alone in Stage II Nasopharyngeal Carcinoma: A Systemic Review and Meta-analysis of 2138 Patients.Efficacy of Concurrent Chemotherapy for Intermediate Risk NPC in the Intensity-Modulated Radiotherapy Era: a Propensity-Matched Analysis.Dose-volume relationships for moderate or severe neck muscle atrophy after intensity-modulated radiotherapy in patients with nasopharyngeal carcinoma.Comparison of long-term survival and toxicity of simultaneous integrated boost vs conventional fractionation with intensity-modulated radiotherapy for the treatment of nasopharyngeal carcinoma.Circulating EBV DNA, Globulin and Nodal Size Predict Distant Metastasis after Intensity-Modulated Radiotherapy in Stage II Nasopharyngeal Carcinoma.A new staging system for nasopharyngeal carcinoma based on intensity-modulated radiation therapy: results of a prospective multicentric clinical study.Prognostic impact of family history in southern Chinese patients with undifferentiated nasopharyngeal carcinomaPrognostic value of ABO blood group in southern Chinese patients with established nasopharyngeal carcinomaPrognostic scoring system for locoregional control among the patients with nasopharyngeal carcinoma treated by intensity-modulated radiotherapy.Comparison of TNM staging systems for nasopharyngeal carcinoma, and proposal of a new staging system.Recommendations for Updating T and N Staging Systems for Nasopharyngeal Carcinoma in the Era of Intensity-Modulated Radiotherapy.Prognostic factors and failure patterns in non-metastatic nasopharyngeal carcinoma after intensity-modulated radiotherapy.Serum proteomic-based analysis identifying autoantibodies against PRDX2 and PRDX3 as potential diagnostic biomarkers in nasopharyngeal carcinomaInvestigation of long-term survival outcomes and failure patterns of patients with nasopharyngeal carcinoma receiving intensity-modulated radiotherapy: a retrospective analysis.Intensity-modulated radiation therapy achieves better local control compared to three-dimensional conformal radiation therapy for T4-stage nasopharyngeal carcinomaMicroRNA-101 inhibits invasion and angiogenesis through targeting ITGA3 and its systemic delivery inhibits lung metastasis in nasopharyngeal carcinoma.Evaluation of 7th Edition of AJCC Staging System for Nasopharyngeal Carcinoma.Repeat biopsy of primary disease negatively affects the outcome of patients with nasopharyngeal cancer treated with definitive intensity-modified radiotherapy: a cohort analysis of 795 patients.Effects of induction docetaxel, platinum, and fluorouracil chemotherapy in patients with stage III or IVA/B nasopharyngeal cancer treated with concurrent chemoradiation therapy: Final results of 2 parallel phase 2 clinical trials.Galectin-1 overexpression in nasopharyngeal carcinoma: effect on survival.Pretreatment Nomograms for Local and Regional Recurrence after Radical Radiation Therapy for Primary Nasopharyngeal Carcinoma.Use of pretreatment serum uric acid level to predict metastasis in locally advanced nasopharyngeal carcinoma.Impact of primary tumor volume and location on the prognosis of patients with locally recurrent nasopharyngeal carcinoma.
P2860
Q26995560-9C2467B8-47EC-4FA7-B6EA-AF1938724C74Q33428012-424A9682-8125-43CA-A8DB-4B41D696F908Q33442582-27A5A545-B75D-4D91-A4AB-96EC4270B696Q33752579-351DD7C2-F503-4A16-BAA3-758F61DC797CQ33967422-146671F9-EBCD-46B8-BDAE-84C998CBD92CQ34352211-506A0F91-540B-42ED-B5FF-D7930CD57893Q35103235-50772E9B-ABA0-4779-B291-EEFB6B59091BQ35521570-D5972505-95DC-4E52-9E85-D777F2F89B91Q35640038-51EDFBB9-3B5C-4751-9B49-A00FF9900EFFQ35732890-1884757C-AD3F-4862-8F8E-2FC9F52540F0Q35763706-C4216789-43CD-482D-94BD-0F66E82059E7Q35823316-089149F4-7FD0-4D63-830A-E6A3503CB684Q35860283-8226541D-31EB-440F-B3D1-C192A869BF25Q35921982-E73E185F-76EF-431D-97FA-276DFBA5B153Q36156092-850B832B-3FAF-473E-A94F-7DD49E556C8CQ36186846-AE8A275F-C91B-4FE7-9C91-41A28D2EAE45Q36275495-F2D4CEAA-F08C-47CB-8F2F-7C05A3D3148CQ36292553-C3737248-730F-4BCE-B280-2E486E380A8EQ36324291-E7B276E6-B7F6-46DE-BACC-7F8AB33D4FA9Q36382531-0CCCD587-EBE5-41DE-A755-CC1587F79D42Q36766858-448B64D7-68E9-47DF-B537-848C385A6D2CQ36792351-5F88C6E0-62B6-44DD-AD4F-B85B2FAD6F1BQ37046856-CDE7DC74-D2A8-4975-A3D2-3358758CF69DQ37081900-033A9562-1AD0-4F62-866E-245B80085EFCQ37279227-484104B9-AF6E-4A3B-8585-7494239BC106Q37353991-58F057F7-1199-4C96-9B71-8AB2970AFC4DQ37385246-58E342CD-2C7C-42C0-AFD5-BDD73E4086DEQ37503143-97953108-C1E9-417A-B082-9781DBF57B91Q37539740-A51E8B34-BA50-4F05-B58F-A15D699D0E8FQ37621102-21B741BE-DB45-4755-8F31-866F51CBFCEEQ37699348-C94C6FE2-E266-4FDF-8C96-46CC3F7C3390Q37706752-4D378028-BF23-47AF-838B-4CB61DCDC706Q37744968-3FFF612C-2C2F-4096-BE71-357E40895D28Q38642001-3347970E-07F8-4406-8C74-F9B34B28A9B3Q38728596-1DE81F6F-B543-4D1E-ADC6-2847715BDD33Q38963962-EF1EA04C-F147-4C9E-84E5-47535A7880C9Q39013952-3F7E2FCD-0BE3-4B37-95D2-CA6499923FEBQ40044365-76D7A4C4-8BE3-4ACB-AACA-1DC33E8CF1BBQ40416235-E96D296E-AB4C-4DA4-89A2-5CDF7B252A92Q41358382-D39C0154-3DC6-4ABC-B9A4-7D6665CD3B10
P2860
The seventh edition of the UICC/AJCC staging system for nasopharyngeal carcinoma is prognostically useful for patients treated with intensity-modulated radiotherapy from an endemic area in China.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
The seventh edition of the UIC ...... from an endemic area in China.
@en
The seventh edition of the UIC ...... from an endemic area in China.
@nl
type
label
The seventh edition of the UIC ...... from an endemic area in China.
@en
The seventh edition of the UIC ...... from an endemic area in China.
@nl
prefLabel
The seventh edition of the UIC ...... from an endemic area in China.
@en
The seventh edition of the UIC ...... from an endemic area in China.
@nl
P2093
P1476
The seventh edition of the UIC ...... from an endemic area in China.
@en
P2093
Ai-Hua Lin
Fang-Yun Xie
Li-Zhi Liu
Yan-Ping Mao
P304
P356
10.1016/J.RADONC.2011.10.009
P577
2011-11-19T00:00:00Z